The Latest Breaking News from UQ

For many parents, the reality of juggling the demands of caring responsibilities on their time, energy and resources leaves them with little time to take care of their own wellbeing. This can result in “parental burnout”.

When people think about child maltreatment, many think of physical or sexual abuse. But a key finding of our Australian Child Maltreatment Study, published last month, is that emotional abuse is widespread and associated with similar harms as sexual abuse.

QUT student Caila Frost hasn't eaten fresh fruit and vegetables in more than a month, and lives on two-minute noodles, as cost of living bites.

Our new study published in Nature Geoscience on an ancient chain of Australian volcanoes is helping to change our understanding of “hotspot” volcanism.

A human trial has been launched into the University of Queensland's second-generation COVID vaccine, more than two years after the original technology was abandoned amid patients falsely testing positive to HIV.

Many children come down with a case of the back-to-school blues as summer slips away. Having spent the holidays staying up late and having fun with friends and family, it can be a struggle to get back into a routine.

You’re running late for work, your eight-year-old can’t find the homework they were supposed to have put in their school bag last night, your four-year-old objects to the blue t-shirt you’d prepared and wants the other shade of blue, and then you step on a Lego piece that didn’t get…

The new year often means a new season of kids’ sports. Many families may be pondering whether to commit to another season or discovering their child is now saying they’d like to quit their usual sport.

The University of Queensland's vaccine had to be abandoned during the rush to develop an effective COVID-19 shot, but now will be trialled on people.

A University of Queensland-led study finds COVID-19 activates a similar inflammatory response to Parkinson's disease, but scientists warn it's too early to cause alarm with more work needed into how the virus affects the brain.

Recent studies had shown the app had a 92 per cent success rate in diagnosing the virus among symptomatic patients, but more clinical trials were needed for it to gain regulatory approval.